Arcturus Therapeutics Holdings ARCT
NASDAQ ARCT
$15.82 +0.26 (+1.67%)
As of: Sep 4, 2026 · 3:59 PM EDT

Arcturus Therapeutics Holdings (ARCT) Asset Utilization Ratio (2019 - 2026)

Arcturus Therapeutics Holdings' (ARCT) quarterly Asset Utilization Ratio came in at 0.21 in Q1 2026, down 50.18% YoY from 0.43 in Q1 2025, and down 28.54% on a QoQ basis from 0.3 in Q4 2025.

Analysis

Arcturus Therapeutics Holdings (ARCT) Asset Utilization Ratio (2019 - 2026) Analysis & Trends

Arcturus Therapeutics Holdings (ARCT) has 8 years of Asset Utilization Ratio data on file, last reported at 0.21 in Q1 2026.

  • Quarterly Asset Utilization Ratio fell 50.18% year-over-year to 0.21 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.21 (down 50.18% YoY) and the FY2025 annual result came in at 0.27, down 32.29% from the prior year.
  • Asset Utilization Ratio retreated to 0.21 in Q1 2026, from 0.3 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.67 in Q3 2023 to a low of 0.04 in Q1 2022.
  • A 5-year average of 0.37 and a median of 0.38 in 2025 frame the typical range for Asset Utilization Ratio.
  • Annual changes were most pronounced in 2022 — Asset Utilization Ratio soared 1753.49% — and 2024, when it sank 51.88%.
  • Tracing ARCT's Asset Utilization Ratio over 5 years: stood at 0.55 in 2022, then tumbled by 32.09% to 0.38 in 2023, then gained by 13.33% to 0.43 in 2024, then slumped by 30.45% to 0.3 in 2025, then slipped by 28.54% to 0.21 in 2026.
  • The last three Asset Utilization Ratio figures came in at 0.21 (Q1 2026), 0.3 (Q4 2025), and 0.33 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 0.47
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 0.38
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 0.20
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 0.69
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 0.90
8 Royalty Pharma 28.45 Bn 27.61 Bn - 0.13
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 0.54
10 Arcturus Therapeutics Holdings 449.65 Mn 258.17 Mn - 0.13
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.13
Mar 31, 2026 0.21
Dec 31, 2025 0.30
Sep 30, 2025 0.33
Jun 30, 2025 0.38
Mar 31, 2025 0.43
Dec 31, 2024 0.43
Sep 30, 2024 0.42
Jun 30, 2024 0.41
Mar 31, 2024 0.29
Dec 31, 2023 0.38
Sep 30, 2023 0.67
Jun 30, 2023 0.59
Mar 31, 2023 0.61
Dec 31, 2022 0.55
Sep 30, 2022 0.16
Jun 30, 2022 0.12
Mar 31, 2022 0.04
Dec 31, 2021 0.03
Sep 30, 2021 0.02